Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2021
Ivantis and Glaukos settle patent litigation
Settlement
Ivantis announced that it had entered into an agreement with Glaukos to settle and dismiss all pending global litigation between them. The terms include payments by Ivantis, royalties on specified Hydrus Microstent sales, and a limited cross-license and covenant not to sue.
Source excerpt
Under the agreement's terms, Ivantis has agreed to pay a total of ® MicrostentUS$60,000,000 in two installments before the end of 2022, and a 10% royalty on Hydrus Microstents sold or made in or imported into the United States through April 26, 2025.
today announced that it has entered into an agreement with Glaukos Corporation to settle and dismiss all pending global litigation between them.